Real ChatGPT answer · index seedLP3mxxu8CwQcompleteHealth and wellness · vision carecommercial

What are the most effective prescription eye drops currently prescribed by ophthalmologists to manage chronic dry eye disease exacerbated by prolonged HVAC exposure in modern offices?

ChatGPTgpt-62 queries11/1/2026
Download run

Fan-out diagram

The searches the AI actually ran for this prompt.

SEED QUERY
What are the most effective prescription eye drops currently prescribed by ophthalmologists to manage chronic dry eye disease exacerbated by prolonged HVAC exposure in modern offices?
2 real searches · 1 real-search pass
2025 2026 chronic dry eye prescription treatments ophthalmology cyclosporine lifitegrast perfluorohexyloctane clinical guidelineGoogle ↗
OBSERVED
FDA prescribing information Vevye Cequa Restasis Xiidra Miebo dry eye indications onset adverse effectsGoogle ↗
OBSERVED

Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.

Query classes

Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.

Classifying 2 queries…

Searches and sources

ChatGPT2 real searches · gpt-6
2025 2026 chronic dry eye prescription treatments ophthalmology cyclosporine lifitegrast perfluorohexyloctane clinical guideline Google ↗
FDA prescribing information Vevye Cequa Restasis Xiidra Miebo dry eye indications onset adverse effects Google ↗
  1. These highlights do not include all the information needed to use MIEBO safely and effectively. See full prescribing information for MIEBO. MIEBO ®(perfluorohexyloctane ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2023 · dailymed.nlm.nih.gov
  2. Improved Dry Eye Drugs for 2025 and Beyond · aao.org
  3. These highlights do not include all the information needed to use MIEBO safely and effectively. See full prescribing information for MIEBO. MIEBO ®(perfluorohexyloctane ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2023 · dailymed.nlm.nih.gov
  4. These highlights do not include all the information needed to use VEVYE ®safely and effectively. See full prescribing information for VEVYE. VEVYE (cyclosporine ophthalmic solution) 0.1%, for topical ophthalmic use Initial U.S. Approval: 1983 · dailymed.nlm.nih.gov
  5. Review · accessdata.fda.gov
  6. These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA ®(lifitegrast ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2016 · dailymed.awsprod.nlm.nih.gov
  7. Dry Eye Syndrome PPP 2023 · aao.org
  8. Medications for Dry Eye Disease · nyulangone.org
  9. TFOS DEWS III: Management and Therapy · doi.org
  10. TFOS DEWS III: Management and Therapy · sciencedirect.com
  11. AAO Dry Eye Syndrome Guideline Summary 2024 Preferred Practice Pattern · guidelinecentral.com
  12. Dry Eye Syndrome (Management Recommendations) (continued) · aao.org
  13. Drug Trials Snapshot: TRYPTYR · fda.gov
  14. These highlights do not include all the information needed to use TRYPTYR® safely and effectively. See full prescribing information for TRYPTYR . TRYPTYR (acoltremon ophthalmic solution) 0.003%,  for topical ophthalmic use Initial U.S. Approval: 2025 · dailymed.nlm.nih.gov

Queries

2 queries · click a column to sort
Query / typeSearchIntentQuery classRouting formatClusterFreq ↓Weight
2025 2026 chronic dry eye prescription treatments ophthalmology cyclosporine lifitegrast perfluorohexyloctane clinical guideline
OBSERVED
Google ↗
AI Mode ↗
————1x
of 1
FDA prescribing information Vevye Cequa Restasis Xiidra Miebo dry eye indications onset adverse effects
OBSERVED
Google ↗
AI Mode ↗
————1x
of 1